BR112022005608A2 - Inibidores de jak - Google Patents

Inibidores de jak

Info

Publication number
BR112022005608A2
BR112022005608A2 BR112022005608A BR112022005608A BR112022005608A2 BR 112022005608 A2 BR112022005608 A2 BR 112022005608A2 BR 112022005608 A BR112022005608 A BR 112022005608A BR 112022005608 A BR112022005608 A BR 112022005608A BR 112022005608 A2 BR112022005608 A2 BR 112022005608A2
Authority
BR
Brazil
Prior art keywords
jak inhibitors
jak
inhibitors
disorders
diseases
Prior art date
Application number
BR112022005608A
Other languages
English (en)
Inventor
Mohan Raju
Nuss John
Harris Jason
Yuan Shendong
Original Assignee
Vimalan Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vimalan Biosciences Inc filed Critical Vimalan Biosciences Inc
Publication of BR112022005608A2 publication Critical patent/BR112022005608A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Abstract

INIBIDORES DE JAK. São descritos nesse documento inibidores de Janus quinase (JAK) e métodos de utilização de inibidores de JAK no tratamento de doenças, distúrbios ou condições. Também são descritas nesse documento composições farmacêuticas contendo tais compostos.
BR112022005608A 2019-09-25 2020-09-24 Inibidores de jak BR112022005608A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962905958P 2019-09-25 2019-09-25
PCT/US2020/052556 WO2021062036A1 (en) 2019-09-25 2020-09-24 Jak inhibitors

Publications (1)

Publication Number Publication Date
BR112022005608A2 true BR112022005608A2 (pt) 2022-09-06

Family

ID=75165340

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022005608A BR112022005608A2 (pt) 2019-09-25 2020-09-24 Inibidores de jak

Country Status (8)

Country Link
US (1) US20230024521A1 (pt)
EP (1) EP4034107A4 (pt)
JP (1) JP2022549435A (pt)
CN (1) CN115003300A (pt)
AU (1) AU2020354629A1 (pt)
BR (1) BR112022005608A2 (pt)
IL (1) IL291611A (pt)
WO (1) WO2021062036A1 (pt)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG151327A1 (en) * 2005-09-30 2009-04-30 Vertex Pharmaceuticals Incopor Deazapurines useful as inhibitors of janus kinases
TWI398252B (zh) * 2006-05-26 2013-06-11 Novartis Ag 吡咯并嘧啶化合物及其用途
WO2012143320A1 (en) * 2011-04-18 2012-10-26 Cellzome Limited (7h-pyrrolo[2,3-d]pyrimidin-2-yl)amine compounds as jak3 inhibitors
NZ702571A (en) * 2012-06-29 2017-02-24 Pfizer 4-(substituted-amino)-7h-pyrrolo[2,3-d]pyrimidines as lrrk2 inhibitors
CN108864057B (zh) * 2017-05-16 2020-03-31 山东大学 含有4-氨基吡唑结构的jak与hdac双靶点抑制剂及其制备方法和应用

Also Published As

Publication number Publication date
US20230024521A1 (en) 2023-01-26
JP2022549435A (ja) 2022-11-25
CN115003300A (zh) 2022-09-02
EP4034107A4 (en) 2023-08-30
WO2021062036A1 (en) 2021-04-01
EP4034107A1 (en) 2022-08-03
AU2020354629A1 (en) 2022-04-21
IL291611A (en) 2022-05-01

Similar Documents

Publication Publication Date Title
BR112021022380A2 (pt) Inibidores de jak
BR112018012756A2 (pt) compostos heterocíclicos como imunomoduladores
JOP20220087A1 (ar) أمينات ثنائية الحلقة كمثبطات لـ cdk2
EA202091709A1 (ru) Ингибиторы днк-пк
MX2022001940A (es) Compuestos de imidazolil pirimidinilamina como inhibidores de cdk2.
MX2020014245A (es) Inhibidores de quinasas dependientes de ciclinas.
MX2022015272A (es) Inhibidores de la proteina kras g12c y usos de estos.
BR112017003054A2 (pt) compostos de aminopirimidinila como inibidores de jak
BR112021019070A2 (pt) Ligantes de pseudoquinase tyk2
BR112021015616A2 (pt) Ligantes de pseudoquinase tyk2
NO20071240L (no) Terapeutiske anvendelser av RTP801 inhibitorer
BR112019001439A8 (pt) compostos e composições e usos dos mesmos
NO20082476L (no) Bicykliske forbindelser med kinaseinhiberende aktivitet
MX2022004937A (es) Inhibidores de las cinasas raf.
EA202091708A1 (ru) Ингибиторы днк-пк
BR112022008821A2 (pt) Ligantes de pseudoquinase tyk2
PH12020550986A1 (en) Heterocyclylamino-substituted triazoles as modulators of rho-associated protein kinase
MX2021006619A (es) Inhibidores de la tirosina quinasa, composiciones y sus metodos.
MX2022009762A (es) Moduladores del purinorreceptor 3 p2x (p2x3).
CR20230362A (es) Inhibidores de cdk2 y métodos de uso de los mismos
BR112022000855A2 (pt) Moduladores de nlrp3
BR112023016614A2 (pt) Inibidores de tyk2 e usos dos mesmos
BR112022018480A2 (pt) Moduladores de nlrp3
BR112022002390A2 (pt) Inibidores de jak
BR112021014566A2 (pt) Moduladores de gpr35

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]